CanSino Biologics Inc - ESG Rating & Company Profile powered by AI
The report of CanSino Biologics Inc leverages intelligence from across the web and also from available disclosures by CanSino Biologics Inc. The webpage is a zero-cost Sustainability report covering CanSino Biologics Inc. The Disclosure score includes seventeen UN Sustainable Development Goals including: 'Zero Hunger', 'Decent Work & Economic Growth' and 'Life on Land'.
CanSino Biologics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.7; made up of an environmental score of 5.3, social score of 6.9 and governance score of 8.0.
6.7
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 314 | Trulieve Cannabis Corp | 6.8 | High |
| 314 | Vicore Pharma Holding AB | 6.8 | High |
| 337 | CanSino Biologics Inc | 6.7 | High |
| 337 | Calyxt Inc | 6.7 | High |
| 337 | Celemics Inc | 6.7 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does CanSino Biologics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes CanSino Biologics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes CanSino Biologics Inc report the average age of the workforce?
Sign up for free to unlockDoes CanSino Biologics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes CanSino Biologics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes CanSino Biologics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes CanSino Biologics Inc offer flexible work?
Sign up for free to unlockDoes CanSino Biologics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes CanSino Biologics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes CanSino Biologics Inc conduct supply chain audits?
Sign up for free to unlockDoes CanSino Biologics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes CanSino Biologics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes CanSino Biologics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes CanSino Biologics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes CanSino Biologics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes CanSino Biologics Inc disclose water use targets?
Sign up for free to unlockDoes CanSino Biologics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid CanSino Biologics Inc have a product recall in the last two years?
Sign up for free to unlockDoes CanSino Biologics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes CanSino Biologics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas CanSino Biologics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes CanSino Biologics Inc disclose parental leave metrics?
Sign up for free to unlockDoes CanSino Biologics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes CanSino Biologics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes CanSino Biologics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes CanSino Biologics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes CanSino Biologics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes CanSino Biologics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs CanSino Biologics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes CanSino Biologics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes CanSino Biologics Inc disclose its waste policy?
Sign up for free to unlockDoes CanSino Biologics Inc report according to TCFD requirements?
Sign up for free to unlockDoes CanSino Biologics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes CanSino Biologics Inc disclose energy use targets?
Sign up for free to unlockDoes CanSino Biologics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes CanSino Biologics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for CanSino Biologics Inc
These potential risks are based on the size, segment and geographies of the company.
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It also develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. Further, the company develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; and TB Booster for the BCG-vaccinated population which is in Phase I clinical trial. In addition, it is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CSB012 to treat adenovirus; CSB013 for ZIKA virus; CSB015 to treat meningitis; CSB016 for treating shingles; and CSB107 for polio. CanSino Biologics Inc. was incorporated in 2009 and is headquartered in Tianjin, the People's Republic of China.